Jul 23, 2026
Advanced Testing Methods Show Promise in Detecting Lung Cancer Biomarkers and Monitoring Disease
New research demonstrates that RNA-based testing can improve detection of MET exon 14 skipping mutations in lung cancer patients, while circulating tumor DNA (ctDNA) testing is increasingly being adopted for early cancer detection and treatment monitoring across oncology.
2 sources
00